People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AavantiBio, Inc. | — | Biotechnology | Series C | $41.8M | $1.5B | 2020 |
Manuela J. Corti, PT, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Manuela J. Corti, PT, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DOUGLAS J. SWIRSKY | 1 | 5 |
| Philip R. Johnson, M.D. | 1 | 2 |
| Benjamin R. Lund | 1 | 2 |
| Bo Cumbo | 1 | 1 |
| Barry J. Byrne, M.D., Ph.D. | 1 | 1 |
| Jake R. Simson | 1 | 1 |
| Ellen J. Hukkelhoven, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.